ArticleScientific reports2026
Prevalence of cervical human papillomavirus infections and cytological abnormalities in asymptomatic women living with HIV in Addis Ababa, Ethiopia.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cervical cancer from persistent HPV infection is the leading cause of cancer death among Sub-Saharan African women. We here addressed the existing knowledge gap concerning the prevalence of HPV infection and cervical lesions in asymptomatic women living with HIV (WLWH) in Addis Ababa, Ethiopia. Adult WLWH (N = 334) were recruited at the HIV clinic of the Tikur Anbessa Specialized Hospital, Addis Ababa. Real-time PCR targeting 12 high-risk (HR) and 2 low-risk HPV types on cervical samples and Pap smear testing were performed. Logistic regression was used in IBM SPSS Statistics to identify factors associated with HPV infection and abnormal cytology. HR-HPV infections occurred in 20.6% of participants and the most prevalent HR-HPV genotypes were HPV35 (16.8%) and HPV16 (14.7%). Abnormal cytology was more common among HR-HPV-positive women than HR-HPV-negative women (36.1% vs. 12.6%, p < 0.0001). LSIL and HSIL were detected in 9.9% and 6.6% of HR-HPV-positive women, respectively. Condom use was associated with reduced odds of HPV infection and abnormal cytology. HR-HPV infections dominated by non-HPV16/18 types and abnormal cytology were common among asymptomatic WLWH in Ethiopia underscoring the need for strengthened cervical cancer screening, HPV vaccinations and safe-sex education for this high-risk population.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.